Jefferies & Co. Slightly "Slows Its Roll" -- On Whitehouse Station

Not a big deal, here on a quiet news day, because Jefferies had been a little ahead of the rest of the pack, earlier this Spring, in predicting a $63 handle for Merck.

Now, the Jefferies analysts are falling back into the middle -- in choosing a $60 handle. That's the revised 12 month target -- with a continuing neutral rating.

As I say, consensus (among the major, first rate Wall Street houses, at least) is somewhere around $60.50 at the moment.

Now. . . do go get it. . . all nice -- and tanned up! It is sunscreen season!